Egis is present in more than 65 countries with its products.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the business year of 2018/2019, we spent around EUR 50 million on research and development
Our highlighted past and future events you shouldn't miss
Egis World
Egis is present in more than 65 countries with its products.

Three Egis Subsidiaries Among the Best Employers

Following the success of Egis Russia and Egis Polska, we are proud to announce that Egis Praha has also been recognized as Best Employer at Aon Hewitt’s Employee Engagement Survey.

More

Gran Prize - Egis Innovation for Sustainability

Egis has developed a new procedure for the dehalogenation of technological wastewaters. In 2018, the Swedish Chamber of Commerce in Hungary recognized the innovation with the Gran Prize Interdisciplinary Innovative award.

More

Egis Strengthens European Presence in the Biosimilar Area

Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries.

More
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Innovation
In the business year of 2018/2019, we spent around EUR 50 million on research and development

International Digital Idea Challenge EGIS

EGIS Polska team among 5 winners of the first edition of International Digital Idea Challenge EGIS.

More
Events
Our highlighted past and future events you shouldn't miss

New Unit Inaugurated at Egis’s Körmend Plant

Egis and our consortia partners have won 2,332 billion HUF direct grant in the framework of the innovation tender GINOP-2.2.1-15-2016-00023 for the realisation of the above-mentioned project.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox